Acorn Financial Advisory Services Inc Petros Pharmaceuticals, Inc. Transaction History

Acorn Financial Advisory Services Inc

  • $508 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 15, 2021
SELL
$1.82 - $3.2 $91,364 - $160,640
-50,200 Closed
0 $0
Q2 2021

Jul 23, 2021
SELL
$2.87 - $4.11 $35,875 - $51,375
-12,500 Reduced 19.94%
50,200 $157,000
Q4 2020

Jan 25, 2021
BUY
$3.24 - $4.68 $203,148 - $293,436
62,700 New
62,700 $276,000

About Petros Pharmaceuticals, Inc.

PTPI Quotes by TradingView
  • Ticker PTPI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 20,708,000
  • Market Cap $6.42M
  • Description
  • Petros Pharmaceuticals, Inc., a pharmaceutical company, focuses on men's health therapeutics. The company engages in the commercialization and development of Stendra, an PDE-5 inhibitor prescription medication for the treatment of erectile dysfunction (ED). It also develops and commercializes H100, a patented topical formulation candidate for th...
More about PTPI
Track This Portfolio

Track Acorn Financial Advisory Services Inc Portfolio

Follow Acorn Financial Advisory Services Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Acorn Financial Advisory Services Inc , based on Form 13F filings with the SEC.

News

Stay updated on Acorn Financial Advisory Services Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email